NO883040L - Means for the examination of tumors, as well as methods for the preparation of such a drug. - Google Patents

Means for the examination of tumors, as well as methods for the preparation of such a drug.

Info

Publication number
NO883040L
NO883040L NO88883040A NO883040A NO883040L NO 883040 L NO883040 L NO 883040L NO 88883040 A NO88883040 A NO 88883040A NO 883040 A NO883040 A NO 883040A NO 883040 L NO883040 L NO 883040L
Authority
NO
Norway
Prior art keywords
tumors
examination
drug
preparation
methods
Prior art date
Application number
NO88883040A
Other languages
Norwegian (no)
Other versions
NO883040D0 (en
Inventor
Sirkka-Liisa Karonen
Hanno Aronen
Jan Lindgren
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of NO883040D0 publication Critical patent/NO883040D0/en
Publication of NO883040L publication Critical patent/NO883040L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Optics & Photonics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Motorcycle And Bicycle Frame (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

The vehicle consists of tissue plasminogen activator or an essential part thereof and is used both for the diagnosis and therapy of malignant tumours.
NO88883040A 1987-07-08 1988-07-07 Means for the examination of tumors, as well as methods for the preparation of such a drug. NO883040L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873722522 DE3722522A1 (en) 1987-07-08 1987-07-08 USE OF A VEHICLE WITH HIGH AFFINITY TO TUMORS

Publications (2)

Publication Number Publication Date
NO883040D0 NO883040D0 (en) 1988-07-07
NO883040L true NO883040L (en) 1989-01-09

Family

ID=6331118

Family Applications (1)

Application Number Title Priority Date Filing Date
NO88883040A NO883040L (en) 1987-07-08 1988-07-07 Means for the examination of tumors, as well as methods for the preparation of such a drug.

Country Status (13)

Country Link
EP (1) EP0298436B1 (en)
JP (1) JPH01125331A (en)
KR (1) KR890001508A (en)
AT (1) ATE81473T1 (en)
AU (1) AU623080B2 (en)
DE (2) DE3722522A1 (en)
DK (1) DK167561B1 (en)
ES (1) ES2046244T3 (en)
FI (1) FI883177A7 (en)
GR (1) GR3006404T3 (en)
NO (1) NO883040L (en)
NZ (1) NZ225350A (en)
ZA (1) ZA884870B (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA831399B (en) * 1982-03-05 1984-02-29 Health Lab Service Board New fibrinolytic enzymes and methods for their production and pharmaceutical compositions containing them
US4663146A (en) * 1983-07-29 1987-05-05 Codon Genetic Engineering Laboratories Methods and compositions for the diagnosis of bloodclots using plasminogen activator

Also Published As

Publication number Publication date
EP0298436A2 (en) 1989-01-11
DK167561B1 (en) 1993-11-22
NO883040D0 (en) 1988-07-07
ES2046244T3 (en) 1994-02-01
AU1889588A (en) 1989-01-12
DK377588D0 (en) 1988-07-07
FI883177A0 (en) 1988-07-04
ATE81473T1 (en) 1992-10-15
JPH01125331A (en) 1989-05-17
ZA884870B (en) 1989-04-26
NZ225350A (en) 1991-07-26
GR3006404T3 (en) 1993-06-21
EP0298436A3 (en) 1990-01-17
DE3875290D1 (en) 1992-11-19
FI883177L (en) 1989-01-09
FI883177A7 (en) 1989-01-09
EP0298436B1 (en) 1992-10-14
DK377588A (en) 1989-01-09
AU623080B2 (en) 1992-05-07
KR890001508A (en) 1989-03-27
DE3722522A1 (en) 1989-01-19

Similar Documents

Publication Publication Date Title
AU5299393A (en) Low-power x-ray source with implantable probe for treatment of brain tumors
EP0505357A4 (en)
DE68912334D1 (en) IMMUNOCONJUGATES FOR CANCER DIAGNOSIS AND THERAPY.
NO862096L (en) PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS CONTAINING Tissue PLASMINOGEN ACTIVATOR.
BG42837A3 (en) METHOD FOR OBTAINING IMMUNOGLOBULIN DERIVATIVES OF VINCA ALKALOIDS
NO165922C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE ESTERS OF HEXAHYDRO-8-HYDROXY-2,6-METHANO-2H-QUINOLIZIN-3- (4H) -ON AND RELATED COMPOUNDS.
EP0210351A3 (en) Use of porphyrin derivatives in the detection and treatment of tumours
SE8404283L (en) APPLICATION OF A SPECIFIC TUMORALLY ASSOCIATED ANTIGEN, namely SIALOSYLLACTOTETRAUS, FOR DIAGNOSTIC AND THERAPEUTIC PROCEDURES FOR CANCER DISEASES
ATE216266T1 (en) MEDICINAL PRODUCT CONTAINING A LIGAND FOR THE TREATMENT AND/OR DIAGNOSIS OF SOFT TISSUE TUMORS
AU5684086A (en) Use of an aqueous chlorite matrix solution for the treatment of tumors
NO881190D0 (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVITY 9- (BETA-D-DEOXYRIBOFURANOSYL) MUCLEOSIDES.
ES2040765T3 (en) PROCEDURE FOR PREPARING AN AGENT FOR THE TREATMENT OF ANGIOGENIC DISEASES OR TUMORS.
GR880100589A (en) Metalloporfyrines for the inversion of the toxic activity for the tumors treatment
NO872875L (en) MODIFIED TISSUE PLASMIN ACTIVATOR, AS WELL AS PROCEDURE FOR MANUFACTURE OF SUCH.
NO883040D0 (en) AGENT FOR TESTING TUMORS AND PROCEDURE FOR THE PREPARATION OF SUCH A MEDICINE.
AU569354B2 (en) (-)-1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane
NO901995D0 (en) NEW VARIANT OF HUMAN Tissue PLASMINOGEN ACTIVATOR.
ZA877900B (en) Active compounds for preventing tumor metastases
DE3764697D1 (en) MEDICAL PREPARATION CONTAINING T-PA AND THEIR USE.
FI882685A7 (en) Device for intracavitary X-ray therapy for the treatment of malignant rectal tumors
ATE75938T1 (en) THERAPEUTIC AGENT CONTAINING ENANTIOMERS OF PROPAFENONE.
BE862329A (en) MEDICINE BASED ON DEHYDRO-OLIGOPEPTIDES INTENDED FOR THE RESOLUTION OF A TUMOR OR TISSUE
FI903637A0 (en) DIAGNOSTIC ANALYSIS FOR THE CONDITION OF ANALYSIS OF CLINICAL TREATMENT.
FI913531A7 (en) Use of 1,2-benzopyrone derivatives for the treatment of human malignant tumors
AU3430189A (en) Compounds for diagnosis and/or therapy of tumours